Business Context and Reporting Period
Company: Natural Alternatives International, Inc. (NAI)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2003
Business Overview: NAI operates in the private label contract manufacturing and direct-to-consumer marketing of nutritional supplements. The company reported strong sales growth driven by new product introductions and increased volume from its two largest customers.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2003 | Three Months Ended Sep 30, 2002 |
|---|---|---|
| Net Sales | $16,721,000 | $13,136,000 |
| Gross Profit | $4,146,000 | $3,195,000 |
| Gross Margin | 24.8% | 24.3% |
| Operating Income | $630,000 | $403,000 |
| Net Income | $567,000 | $537,000 |
| Diluted EPS | $0.09 | $0.09 |
| Cash and Equivalents | $3,179,000 | $2,824,000 (End of Period 2002) |
| Working Capital | $13,099,000 | $12,321,000 (June 30, 2003) |
| Total Debt | $2,815,000 | $3,000,000 (June 30, 2003) |
| Operating Cash Flow | ($1,792,000) | $1,109,000 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 27% ($3.6 million) year-over-year. Private label contract manufacturing sales rose 30% due to new products and volume increases from top customers. Direct-to-consumer sales grew 15% following the launch of four new products.
- Profitability: Operating income increased 56% to $630,000, driven by a $951,000 increase in gross profit. This was partially offset by a $724,000 increase in selling, general, and administrative (SG&A) expenses.
- Cash Flow Deterioration: Operating cash flow turned negative at ($1.8 million) compared to positive $1.1 million in the prior year. This was primarily due to a $2.6 million increase in inventory to meet customer requirements and anticipated growth.
- One-Time Items: The prior year period included $225,000 in proceeds from a vitamin antitrust litigation settlement, which was not present in the current period. Excluding this, net income increased $255,000 year-over-year.
Guidance, Outlook, and Risks
- Expansion Plans: On October 27, 2003, the company amended its Vista, California lease to add 46,000 square feet, increasing total space to 120,000 square feet. The new space, commencing April 2004, will house tableting and encapsulation operations. Capital expenditures are expected to increase significantly in the remainder of fiscal 2004 to support this expansion.
- Liquidity: The company maintains a $6.5 million credit facility (expiring October 2004) with $4.0 million currently available. Management plans to fund working capital and expansion via operating cash flow and this facility.
- Customer Concentration Risk: Two customers accounted for 69% of net sales in the quarter (41% and 27% respectively). The loss of either customer could materially impact earnings.
- Supplier Concentration Risk: One supplier accounted for 34% of raw material purchases in the quarter.
- Market Risks: The company is exposed to foreign currency fluctuations (Euro and Swiss Franc). A 10% adverse change in exchange rates would have decreased earnings by $271,000 for the quarter. Interest rate risk exists on $2.1 million of variable-rate debt.
Investor Verification Checklist
- Inventory Build: Verify the necessity of the $2.6 million inventory increase and the risk of obsolescence if anticipated sales growth does not materialize.
- Cash Burn: Monitor the negative operating cash flow trend and the company's ability to service debt and fund expansion without additional financing.
- Customer Dependency: Assess the stability of contracts with the two customers representing 69% of revenue.
- Lease Obligations: Confirm the financial impact of the new 10-year lease commitment totaling approximately $13 million in future minimum rentals.
- Capital Expenditures: Track the execution of planned capital expenditures for manufacturing expansion and their impact on future cash flows.